Latest edition of the Journal of Neuromuscular Diseases now online – Apr 2020

A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:

Journal of Neuromuscular Diseases: Volume 7, issue 2

 

*Hanns is joint editor in chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.

 

Articles:

  • Pseudoexons of the DMD gene
  • Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2
  • Relationship between eating and digestive symptoms and respiratory function in advanced Duchenne muscular dystrophy patients
  • Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening – Opportunity or burden?
  • Upregulation of hallmark muscle genes protects Gne M743T/M743T mutated knock-in mice from kidney and muscle phenotype
  • Clinical and genetic features in a series of eight unrelated patients with neuropathy due to Glycyl-tRNA Synthetase (GARS) variants
  • RESTORE: A prospective multinational registry of patients with genetically confirmed spinal muscular atrophy – Rationale and study design
  • Improved criteria for the classification of titin variants in inherited skeletal myopathies
  • Characterizing enrollment in observational studies of Duchenne muscular dystrophy by race and ethnicity
  • The slipping slipper sign: A poor man’s test for severe diabetic peripheral neuropathy
  • Scoliosis surgery significantly impacts motor abilities in higher-functioning individuals with spinal muscular atrophy
  • Paramyotonia congenita with persistent distal and facial muscle weakness: A case report with literature review
Journal of Neuromuscular Diseases

Read next...

New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment...
Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial....
Lessard-funding-DM1_1200x900 (1)

Dr. Lola Lessard Receives Postdoctoral Fellowship to study AMPK signaling in DM1

We are excited to share that  Dr. Lola Lessard has been awarded a one-year postdoctoral research fellowship from AFM-Téléthon to study AMP-activated protein kinase (AMPK)...
Congratulations to the 2024 Lochmuller Lab graduates, Emily Freeman and Catherine Choueiri.

Congratulations to the Lab’s Recent Graduates!

The Lochmüller Lab would like to congratulate two of our members on graduating from PhD and MSc programs at the University of Ottawa this past...